IBT
MIRM icon

International Biotechnology Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

International Biotechnology Trust’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.13M Hold
67,500
– – 0.72% 39
2023
Q2 		$1.74M Hold
67,500
– – 0.53% 39
2023
Q1 		$1.62M Hold
67,500
– – 0.45% 45
2022
Q4 		$1.31M Buy
67,500
+58,281
+632% +$1.15M 0.41% 45
2022
Q3 		$193K Buy
+9,219
New +$222K 0.06% 65

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Biotechnology Trust's MIRM Position: Q3 2023 in Review

International Biotechnology Trust held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2023 at 67,500 shares worth $2.13M. The position accounts for 0.72% of the portfolio, ranked #39.

International Biotechnology Trust first reported a position in MIRM in Q3 2022 and has held it in 5 quarters since. 159 funds tracked by Wall St. Rank hold MIRM as of Q3 2023.

  • International Biotechnology Trust held 67,500 shares of Mirum Pharmaceuticals worth $2.13M as of Q3 2023.
  • International Biotechnology Trust left its Mirum Pharmaceuticals share count unchanged in Q3 2023.
  • Mirum Pharmaceuticals made up 0.72% of International Biotechnology Trust's portfolio in Q3 2023, its #39 holding.
  • International Biotechnology Trust first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • 159 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.